Cellegy Pharmaceuticals, Inc.
Records under this name other than patents Cellegy Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cellegy Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,168,232 | Formulations and methods of using nitric oxide mimetics in cancer treatment Formerly held Lapsed on the fee record Ended May 1, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 1, 2020 | From the USPTO record |
| US 6,165,975 | Microdose therapy Formerly held Term ended Term ended Dec 22, 2019 · From the USPTO record | Term ended | Term ended Dec 22, 2019 | From the USPTO record |
| US 7,157,097 | Penetration Enhancing and Irritation Reducing Systems Formerly held Term ended Term ended Dec 9, 2018 · Medium confidence | Term ended | Term ended Dec 9, 2018 | Medium confidence |
| US 6,319,913 | Penetration enhancing and irritation reducing systems Formerly held Term ended Term ended Nov 9, 2018 · From the USPTO record | Term ended | Term ended Nov 9, 2018 | From the USPTO record |
| US 6,579,865 | Penetration Enhancing and Irritation Reducing Systems Formerly held Term ended Term ended Nov 9, 2018 · Medium confidence | Term ended | Term ended Nov 9, 2018 | Medium confidence |
| US 7,678,391 | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype Formerly held Lapsed on the fee record Ended Mar 16, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 16, 2018 | From the USPTO record |
| US 6,987,129 | Compounds and methods for the treatment of urogenital disorders Lapsed on the fee record Ended Jan 17, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2018 | From the USPTO record |
| US 6,946,484 | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype Formerly held Lapsed on the fee record Ended Sep 20, 2017 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2017 | From the USPTO record |
| US 7,393,825 | Microdose therapy Formerly held Lapsed on the fee record Ended Jul 1, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2016 | From the USPTO record |
| US 6,627,632 | Compositions and methods for the treatment of anorectal disorders Lapsed on the fee record Ended Sep 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Sep 30, 2015 | From the USPTO record |